Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: antiproliferative effects of peptide analogues.
about
Growth Hormone-Releasing Hormone in DiabetesLoss of somatostatin receptor subtype 2 in prostate cancer is linked to an aggressive cancer phenotype, high tumor cell proliferation and predicts early metastatic and biochemical relapseAtomic force microscopy-based microrheology reveals significant differences in the viscoelastic response between malign and benign cell lines.Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic isletsIn vivo fluorescence imaging and urinary monoamines as surrogate biomarkers of disease progression in a mouse model of pheochromocytoma.Transplantation of bovine adrenocortical cells encapsulated in alginate.Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist.Anti-tumor effects of peptide analogs targeting neuropeptide hormone receptors on mouse pheochromocytoma cellsSomatostatin receptor biology in neuroendocrine and pituitary tumours: part 2--clinical implicationsAberrant gonadotropin-releasing hormone receptor (GnRHR) expression and its regulation of CYP11B2 expression and aldosterone production in adrenal aldosterone-producing adenoma (APA).Multimodal Somatostatin Receptor Theranostics Using [(64)Cu]Cu-/[(177)Lu]Lu-DOTA-(Tyr(3))octreotate and AN-238 in a Mouse Pheochromocytoma Model.A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patientsExpression of progenitor markers is associated with the functionality of a bioartificial adrenal cortex.Pattern of adrenal morphology and function in patients with acromegaly.GnRH antagonist treatment of malignant adrenocortical tumors
P2860
Q28070104-C5A5343C-33FD-46D6-8F27-479ECE29C947Q28540624-629D7A7C-0BD1-4E57-8C50-A40E26B19E0EQ33703822-9647E02D-264F-4FC5-BCCA-69C081AB34B8Q34004827-36763C1A-8FB8-43FB-BAFD-D10BF0208E4EQ34636519-6819EC2D-44ED-40FE-B191-8DC5058926ECQ35134522-DBC1B5FD-B882-487B-BE62-18808273A75FQ35882545-E430CFC0-AE8A-4F71-96C8-54A4546DD6FBQ36948906-533F6555-83A1-4144-8EFB-BE822BBADD38Q37772579-438CAF3B-DEAE-422B-B5D5-8E954D7C0904Q39029635-6331C875-89F1-423F-85E4-12FEA93843FEQ39428786-5852ABDD-6612-4BEF-99F5-4D836BE6F5C8Q41555086-095D5037-7DC1-4AC6-82A7-E18F9BBF33BFQ52723246-0CB7A34C-B178-4C47-B2BE-7FEAE9CB1694Q53204823-0FB79AAA-56FB-4150-BC88-DEA0C720EA2EQ58542871-6C5CE328-4F4D-4AEE-8849-216DD5D816B9
P2860
Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: antiproliferative effects of peptide analogues.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Expression of neuropeptide hor ...... effects of peptide analogues.
@en
Expression of neuropeptide hor ...... effects of peptide analogues.
@nl
type
label
Expression of neuropeptide hor ...... effects of peptide analogues.
@en
Expression of neuropeptide hor ...... effects of peptide analogues.
@nl
prefLabel
Expression of neuropeptide hor ...... effects of peptide analogues.
@en
Expression of neuropeptide hor ...... effects of peptide analogues.
@nl
P2093
P2860
P356
P1476
Expression of neuropeptide hor ...... e effects of peptide analogues
@en
P2093
C G Ziegler
G Eisenhofer
H S Willenberg
L M Fishman
M Ehrhart-Bornstein
P2860
P304
15879-15884
P356
10.1073/PNAS.0907843106
P407
P577
2009-08-27T00:00:00Z